Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome Academic Article uri icon


MeSH Major

  • Cerebral Hemorrhage
  • Neoplasms


  • © 2016 Elsevier B.V. Background Posterior reversible encephalopathy syndrome (PRES) is a variable cerebrovascular syndrome associated with hypertension and autoregulatory failure. Steroids have been reported to both precipitate and treat PRES. We sought to determine the prevalence of steroid therapy at the time of PRES and to assess the relationship between steroid therapy and extent of vasogenic edema. Methods We performed a retrospective review of radiology reports between 2008 and 2014 from two academic medical centers to identify cases of PRES. Clinical and radiographic data were collected. Descriptive statistics were used to determine the prevalence of corticosteroid therapy at the time of PRES onset and the latency from steroid initiation to PRES onset. The association between steroid therapy and extent of vasogenic edema was assessed in multiple regression models. Results We identified 99 cases of PRES in 96 patients. The median age was 55 years (IQR 30–65) and 74% were women. Steroid therapy at time of PRES onset was identified in 44 of 99 cases. Excluding patients on chronic therapy, the median duration of steroid exposure before PRES onset was 6 (IQR, 3–10) days. Steroid therapy was not associated with extent of vasogenic edema in unadjusted or linear and logistic regression models adjusted for age, sex, and maximum systolic blood pressure on day of onset. Conclusion Corticosteroid therapy, often of brief duration, frequently preceded the onset of PRES and was not associated with severity of vasogenic edema.

publication date

  • September 15, 2017



  • Academic Article



  • eng

PubMed Central ID

  • PMC5663311

Digital Object Identifier (DOI)

  • 10.1016/j.jns.2017.06.044

PubMed ID

  • 28870548

Additional Document Info

start page

  • 11

end page

  • 15


  • 380